Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06484920
Title A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Rita Assi
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center RECRUITING Indianapolis Indiana 46202 United States Details
Sidney and Lois Eskenazi Hospital RECRUITING Indianapolis Indiana 46202 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field